MAP2K7 and breast cancer: For instance, chi-miR-9-3p has been shown to be an important regulator of osteoblast differentiation in mouse iPS cells and also targets β1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition [44, 45].